Last viewed:
agtc
Prices are updated after-hours
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
(0.0% 1d)
(0.0% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(-80.43%
volume)
Earnings Calendar: 2022-11-08
Market Cap:
http://www.agtc.com
Sec
Filling
|
Patents
| 83 employees
(US) Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.
gene therapies
genetic
clinical trials
add to watch list
Paper trade
email alert is off
Press-releases
Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight
Published: 2024-04-22
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| 0.89%
| O: 0.89%
H: 0.0%
C: 0.0%
OTLK
|
News
P
|
$8.2
0.0%
240K
|
Health Technology
| 1.36%
| O: 1.48%
H: 2.8%
C: -0.12%
OPT
|
News
|
$3.46
2.98%
2.89%
8.2K
|
Health Technology
| -0.59%
| O: 3.25%
H: 0.0%
C: -3.72%
OCUL
|
News
|
$4.645
-7.1%
-7.64%
3.9M
|
Health Technology
| -1.57%
| O: 0.79%
H: 0.59%
C: -2.34%
KOD
|
News
|
$3.37
1.2%
1.19%
340K
|
Health Technology
| -2.63%
| O: 0.29%
H: 3.79%
C: -2.92%
EYPT
|
News
|
$16.47
-6.26%
-6.68%
1.1M
|
Health Technology
| 3.66%
| O: 7.73%
H: 2.3%
C: -3.78%
CLSD
|
News
P
|
$1.33
-2.92%
-3.01%
200K
|
Health Technology
| -2.84%
| O: 1.42%
H: 3.5%
C: -4.2%
ADVM
|
News
|
$10.19
-7.36%
-7.95%
310K
|
Health Technology
| -3.0%
| O: -0.26%
H: 4.95%
C: -2.74%
macular
growth
market
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Published: 2024-03-31
(Crawled : 00:00)
- globenewswire.com
CUBT
|
$0.0254
-42.11%
200K
|
n/a
| 7.14%
| O: 3.57%
H: 0.0%
C: -6.9%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| -4.44%
| O: -0.97%
H: 0.0%
C: 0.0%
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Published: 2024-03-22
(Crawled : 13:30)
- globenewswire.com
CUBT
|
$0.0254
-42.11%
200K
|
n/a
| 5.26%
| O: 19.3%
H: 0.0%
C: -20.59%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| -1.02%
| O: -1.58%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| -0.84%
| O: 1.47%
H: 0.23%
C: -0.19%
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors
Published: 2024-02-08
(Crawled : 13:00)
- globenewswire.com
ACRV
|
$9.46
-3.67%
-3.81%
300K
|
| 169.04%
| O: 5.75%
H: 0.0%
C: -8.29%
VIGL
|
$2.8
5.66%
5.36%
63K
|
| -7.02%
| O: 1.05%
H: 1.52%
C: -1.39%
therapeutics
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032) | DelveInsight `
Published: 2024-01-16
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| -9.29%
| O: -1.83%
H: 0.0%
C: 0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
| 16.46%
| O: 0.77%
H: 0.17%
C: -1.65%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| -8.92%
| O: 0.45%
H: 0.06%
C: -0.5%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
| 4.13%
| O: -0.13%
H: 0.0%
C: -7.15%
ADVM
|
News
|
$10.19
-7.36%
-7.95%
310K
|
Health Technology
| 1263.07%
| O: -0.69%
H: 2.32%
C: -0.12%
therapy
growth
study
market
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Published: 2024-01-08
(Crawled : 15:00)
- globenewswire.com
CUBT
|
$0.0254
-42.11%
200K
|
n/a
| 20.0%
| O: -0.8%
H: 8.87%
C: 8.87%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| -7.14%
| O: 2.07%
H: 0.48%
C: 0.48%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| -7.62%
| O: 1.16%
H: 0.0%
C: 0.0%
A Comprehensive Analysis of Rare Diseases Market With a Focus on Homozygous Familial Hypercholesterolemia, Heparin-induced Thrombocytopenia, Post-Bariatric Hypoglycemia, IgG4-related Disease, and ANCA-associated Vasculitis | DelveInsight
Published: 2023-12-05
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| -0.02%
| O: -2.77%
H: 0.49%
C: 0.49%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| -5.98%
| O: -0.41%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| 1.1%
| O: -0.6%
H: 0.0%
C: 0.0%
IONS
|
$42.455
1.47%
1.45%
730K
|
Health Technology
| -16.32%
| O: 0.18%
H: 0.76%
C: -0.3%
rare
market
Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published: 2023-11-16
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
| 13.94%
| O: -2.04%
H: 0.0%
C: 0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| 1.89%
| O: 1.01%
H: 0.0%
C: -2.65%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
| 3.67%
| O: 0.67%
H: 0.0%
C: 0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
| 5.1%
| O: 0.91%
H: 0.21%
C: -0.01%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| 0.1%
| O: 0.78%
H: 0.0%
C: 0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
| 19.74%
| O: 1.05%
H: 1.44%
C: 1.15%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
| 9.84%
| O: 2.58%
H: 0.0%
C: 0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| 2.17%
| O: 1.42%
H: 0.0%
C: 0.0%
rare
disease
cell
eye
market
The Evolving Market Dynamics of Rare Diseases: WHIM Syndrome, Adrenal Crisis, Molybdenum Cofactor Deficiency Type-A (MoCoD-A), and Necrotizing Enterocolitis | Key Analysis by DelveInsight
Published: 2023-10-17
(Crawled : 21:00)
- prnewswire.com
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| -4.5%
| O: -0.83%
H: 0.35%
C: -1.72%
IONS
|
$42.455
1.47%
1.45%
730K
|
Health Technology
| -13.75%
| O: -0.41%
H: 0.45%
C: -4.82%
rare
whim
market
Global Optogenetics Market Report 2023: Major Players Include Elliot Scientific, Shanghai Laser & Optics Century, GenSight Biologics and Danaher
Published: 2023-06-08
(Crawled : 02:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
| 17.13%
| O: 1.32%
H: 0.0%
C: -0.62%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
| 0.37%
| O: 1.26%
H: 1.08%
C: 0.91%
DHR
|
$250.41
-1.07%
-0.72%
3.3M
|
Health Technology
| 6.56%
| O: 0.0%
H: 0.24%
C: -0.89%
BRKR
|
$82.21
-0.3%
-0.3%
980K
|
Health Technology
| 9.1%
| O: -0.24%
H: 0.45%
C: -1.79%
report
global
laser
market
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount